首页> 外文OA文献 >Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

【2h】

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

机译：Ticagrelor Plus Aspirin持续1个月，其次是TicagreloLo疗法23个月与阿司匹林加氯吡格雷或TiCagreloR 12个月，其次是植入药物洗脱支架后12个月的阿司匹林单药治疗：多期，开放标签，随机的优势试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

相似文献

外文文献
中文文献
专利

1. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial [J] . Vranckx Pascal, Valgimigli Marco, Juni Peter, The Lancet . 2018,第10151期

机译：Ticagrelor Plus Aspirin持续1个月，其次是TicagreloLo疗法23个月与阿司匹林加氯吡格雷或TiCagreloR 12个月，其次是植入药物洗脱支架后12个月的阿司匹林单药治疗：多期，开放标签，随机的优势试验
2. Clopidogrel Versus Aspirin as an Antiplatelet Monotherapy After 12-Month Dual-Antiplatelet Therapy in the Era of Drug-Eluting Stents [J] . Park Taek Kyu, Song Young Bin, Ahn Joonghyun, Circulation. Cardiovascular interventions . 2016,第1期

机译：氯吡格雷与阿司匹林为抗血小板单药治疗后12个月的双抗血小板治疗毒药支架时代后
3. 6-Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel) [J] . Didier Romain, Morice Marie Claude, Barragan Paul, JACC. Cardiovascular interventions . 2017,第12期

机译：6 - 与24个月双抗血小板治疗后植入患者患者患者的孕态审判的Aspirin最终结果（在停止氯吡格雷停止后DES的寿命）
4. Comparison of the cross sectional area, the loss in volume and the mechanical properties of LAE442 and MgCa0.8 as resorbable magnesium alloy implants after 12 months implantation duration [C] . Martina Thomann, Nina von der Hoeh, D. Bormann, International conference on processing manufacturing of advanced materials;THERMEC 2009 . 2009

机译：植入12个月后作为可吸收镁合金植入物的LAE442和MgCa0.8的横截面积，体积损失以及力学性能的比较
5. Adapted motivational interviewing for increasing physical activity: A 12 month clinical trial. [D] . Havenar, Jacob. 2007

机译：适应性动机面试以增加身体活动：一项为期12个月的临床试验。
6. Prospective multicentre open-label randomised controlled trial of 3-month versus 12-month dual antiplatelet therapy after implantation of the new generation biodegradable polymer sirolimus TARGET-eluting coronary stent: protocol of the TARGET DAPT trial [O] . Hongbo Yang, Feng Zhang, Jie Yang, 2019

机译：植入新一代生物可降解聚合物西罗莫司TARGET洗脱冠状动脉支架后的3个月和12个月双重抗血小板治疗的前瞻性多中心开放标签随机对照试验：TARGET DAPT试验方案
7. Prospective multicentre open-label randomised controlled trial of 3-month versus 12-month dual antiplatelet therapy after implantation of the new generation biodegradable polymer sirolimus TARGET-eluting coronary stent: protocol of the TARGET DAPT trial [O] . Hongbo Yang, Feng Zhang, Jie Yang, 2019

机译：前瞻性多期式开放标签随机对照试验3个月与12个月双抗血小板治疗植入新一代生物降解的聚合物西罗莫司靶洗脱冠状动脉支架：目标DAPT试验的协议

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

著录项

引文网络

相似文献

相关主题

期刊订阅